Liraglutide Pretreatment Does Not Improve Acute Doxorubicin-Induced Cardiotoxicity in Rats

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2024 Jun 19

PMID 38892020

Authors

Carolina R Tonon

Marina G Monte

Paola S Balin

Anderson S S Fujimori

Ana Paula D Ribeiro

Natalia F Ferreira

Nayane M Vieira

Ronny P Cabral

Marina P Okoshi

Katashi Okoshi

Leonardo A M Zornoff

Marcos F Minicucci

Sergio A R Paiva

Mariana J Gomes

Bertha F Polegato

Affiliations

Soon will be listed here.

Abstract

Doxorubicin is an effective drug for cancer treatment; however, cardiotoxicity limits its use. Cardiotoxicity pathophysiology is multifactorial. GLP-1 analogues have been shown to reduce oxidative stress and inflammation. In this study, we evaluated the effect of pretreatment with liraglutide on doxorubicin-induced acute cardiotoxicity. A total of 60 male Wistar rats were allocated into four groups: Control (C), Doxorubicin (D), Liraglutide (L), and Doxorubicin + Liraglutide (DL). L and DL received subcutaneous injection of liraglutide 0.6 mg/kg daily, while C and D received saline for 2 weeks. Afterwards, D and DL received a single intraperitoneal injection of doxorubicin 20 mg/kg; C and L received an injection of saline. Forty-eight hours after doxorubicin administration, the rats were subjected to echocardiogram, isolated heart functional study, and euthanasia. Liraglutide-treated rats ingested significantly less food and gained less body weight than animals that did not receive the drug. Rats lost weight after doxorubicin injection. At echocardiogram and isolated heart study, doxorubicin-treated rats had systolic and diastolic function impairment. Myocardial catalase activity was statistically higher in doxorubicin-treated rats. Myocardial protein expression of tumor necrosis factor alpha (TNF-α), phosphorylated nuclear factor-κB (p-NFκB), troponin T, and B-cell lymphoma 2 (Bcl-2) was significantly lower, and the total NFκB/p-NFκB ratio and TLR-4 higher in doxorubicin-treated rats. Myocardial expression of OPA-1, MFN-2, DRP-1, and topoisomerase 2β did not differ between groups ( > 0.05). In conclusion, doxorubicin-induced cardiotoxicity is accompanied by decreased Bcl-2 and phosphorylated NFκB and increased catalase activity and TLR-4 expression. Liraglutide failed to improve acute doxorubicin-induced cardiotoxicity in rats.

Citing Articles

Anti-Diabetic Therapies and Cancer: From Bench to Bedside.

Kounatidis D, Vallianou N, Karampela I, Rebelos E, Kouveletsou M, Dalopoulos V Biomolecules. 2024; 14(11).

PMID: 39595655 PMC: 11591849. DOI: 10.3390/biom14111479.

References

de Paiva S, Mamede Zornoff L, Okoshi M, Okoshi K, Matsubara L, Matsubara B . Ventricular remodeling induced by retinoic acid supplementation in adult rats. Am J Physiol Heart Circ Physiol. 2003; 284(6):H2242-6. DOI: 10.1152/ajpheart.00646.2002. View

Alhumaydhi F . Biochemical studies on the protective effect of honey against doxorubicin-induced toxicity in BALB/C mice. Int J Health Sci (Qassim). 2020; 14(6):31-37. PMC: 7644457. View

Hu C, Zhang X, Wei W, Zhang N, Wu H, Ma Z . Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity maintaining AMPK/UCP2 pathway. Acta Pharm Sin B. 2019; 9(4):690-701. PMC: 6664099. DOI: 10.1016/j.apsb.2019.03.003. View

Park M, Hong J . Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches. Cells. 2016; 5(2). PMC: 4931664. DOI: 10.3390/cells5020015. View

Brock C, Hansen C, Karmisholt J, Moller H, Juhl A, Farmer A . Liraglutide treatment reduced interleukin-6 in adults with type 1 diabetes but did not improve established autonomic or polyneuropathy. Br J Clin Pharmacol. 2019; 85(11):2512-2523. PMC: 6848951. DOI: 10.1111/bcp.14063. View

Lin H, Meng L, Sun Z, Sun S, Huang X, Lin N . Yellow Wine Polyphenolic Compound Protects Against Doxorubicin-Induced Cardiotoxicity by Modulating the Composition and Metabolic Function of the Gut Microbiota. Circ Heart Fail. 2021; 14(10):e008220. DOI: 10.1161/CIRCHEARTFAILURE.120.008220. View

Wu L, Wang L, Du Y, Zhang Y, Ren J . Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity. Trends Pharmacol Sci. 2022; 44(1):34-49. DOI: 10.1016/j.tips.2022.10.003. View

Fouad G, Ahmed K . Curcumin Ameliorates Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity Via Suppressing Oxidative Stress and Modulating iNOS, NF-κB, and TNF-α in Rats. Cardiovasc Toxicol. 2021; 22(2):152-166. DOI: 10.1007/s12012-021-09710-w. View

Chen J, Mei A, Wei Y, Li C, Qian H, Min X . GLP-1 receptor agonist as a modulator of innate immunity. Front Immunol. 2022; 13:997578. PMC: 9772276. DOI: 10.3389/fimmu.2022.997578. View

10.

Aryal B, Jeong J, Rao V . Doxorubicin-induced carbonylation and degradation of cardiac myosin binding protein C promote cardiotoxicity. Proc Natl Acad Sci U S A. 2014; 111(5):2011-6. PMC: 3918758. DOI: 10.1073/pnas.1321783111. View

11.

Elberry A, Abdel-Naim A, Abdel-Sattar E, Nagy A, Mosli H, Mohamadin A . Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats. Food Chem Toxicol. 2010; 48(5):1178-84. DOI: 10.1016/j.fct.2010.02.008. View

12.

Prathumsap N, Shinlapawittayatorn K, Chattipakorn S, Chattipakorn N . Effects of doxorubicin on the heart: From molecular mechanisms to intervention strategies. Eur J Pharmacol. 2019; 866:172818. DOI: 10.1016/j.ejphar.2019.172818. View

13.

Elnoury H, Elgendy S, Baloza S, Ghamry H, Soliman M, Abdel-Aziz E . Synergistic impacts of Montelukast and Klotho against doxorubicin-induced cardiac toxicity in Rats. Toxicol Res (Camb). 2022; 11(4):592-604. PMC: 9424714. DOI: 10.1093/toxres/tfac023. View

14.

Meurot C, Martin C, Sudre L, Breton J, Bougault C, Rattenbach R . Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis. Sci Rep. 2022; 12(1):1567. PMC: 8799666. DOI: 10.1038/s41598-022-05323-7. View

15.

Hansen G, Jelsing J, Vrang N . Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DIO-rats. Acta Pharmacol Sin. 2012; 33(2):194-200. PMC: 4010326. DOI: 10.1038/aps.2011.168. View

16.

Ribeiro A, Pereira A, Todo M, Fujimori A, Santos P, Dantas D . Pera orange (Citrus sinensis) and Moro orange (Citrus sinensis (L.) Osbeck) juices attenuate left ventricular dysfunction and oxidative stress and improve myocardial energy metabolism in acute doxorubicin-induced cardiotoxicity in rats. Nutrition. 2021; 91-92:111350. DOI: 10.1016/j.nut.2021.111350. View

17.

Babaei H, Razmaraii N, Assadnassab G, Mohajjel Nayebi A, Azarmi Y, Mohammadnejad D . Ultrastructural and Echocardiographic Assessment of Chronic Doxorubicin-Induced Cardiotoxicity in Rats. Arch Razi Inst. 2020; 75(1):55-62. PMC: 8410154. DOI: 10.22092/ari.2019.116862.1177. View

18.

Renu K, V G A, P B T, Arunachalam S . Molecular mechanism of doxorubicin-induced cardiomyopathy - An update. Eur J Pharmacol. 2017; 818:241-253. DOI: 10.1016/j.ejphar.2017.10.043. View

19.

Cray P, Sheahan B, Cortes J, Dekaney C . Doxorubicin increases permeability of murine small intestinal epithelium and cultured T84 monolayers. Sci Rep. 2020; 10(1):21486. PMC: 7722747. DOI: 10.1038/s41598-020-78473-1. View

20.

Khan T, Ganaie M, Alharthy K, Madkhali H, Jan B, Sheikh I . Naringenin prevents doxorubicin-induced toxicity in kidney tissues by regulating the oxidative and inflammatory insult in Wistar rats. Arch Physiol Biochem. 2018; 126(4):300-307. DOI: 10.1080/13813455.2018.1529799. View